Cargando…

Pubertal Lipid Levels Are Significantly Lower in Youth With Type 1 Diabetes Who Experienced Partial Clinical Remission

IMPORTANCE: The physiologic changes in lipids during puberty in type 1 diabetes (T1D) are unclear because subjects in previous studies were not stratified by partial clinical remission status. AIM: To determine the effect of partial clinical remission on lipid changes during puberty in youth with T1...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwosu, Benjamin Udoka, Rupendu, Shwetha, Zitek-Morrison, Emily, Patel, Deepa, Villalobos-Ortiz, Tony R, Jasmin, Gabrielle, Barton, Bruce A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436764/
https://www.ncbi.nlm.nih.gov/pubmed/30931423
http://dx.doi.org/10.1210/js.2019-00016
_version_ 1783406857163898880
author Nwosu, Benjamin Udoka
Rupendu, Shwetha
Zitek-Morrison, Emily
Patel, Deepa
Villalobos-Ortiz, Tony R
Jasmin, Gabrielle
Barton, Bruce A
author_facet Nwosu, Benjamin Udoka
Rupendu, Shwetha
Zitek-Morrison, Emily
Patel, Deepa
Villalobos-Ortiz, Tony R
Jasmin, Gabrielle
Barton, Bruce A
author_sort Nwosu, Benjamin Udoka
collection PubMed
description IMPORTANCE: The physiologic changes in lipids during puberty in type 1 diabetes (T1D) are unclear because subjects in previous studies were not stratified by partial clinical remission status. AIM: To determine the effect of partial clinical remission on lipid changes during puberty in youth with T1D. SUBJECTS AND METHODS: A retrospective cross-sectional study of 194 subjects consisting of 71 control subjects of age 12.9 ± 1.3 years and 123 subjects with T1D stratified into remitters (n = 44; age, 13.0 ± 0.8 years) and nonremitters (n = 79; age, 11.2 ± 0.6 years). Partial clinical remission was defined as insulin-dose adjusted HbA1c of ≤9. Pubertal status was determined by Tanner staging. RESULTS: Among the pubertal cohort, low-density lipoprotein cholesterol concentration was significantly higher in the nonremitters compared with remitters (91.1 ± 25.6 vs 77.2 ± 25.8 mg/dL, P = 0.018) and with normal-weight control subjects (91.1 ± 25.6 vs 70.4 ± 22.9 mg/dL, P = 0.009) but was similar between overweight/obese control subjects and nonremitters (89.7 ± 28.9 vs 91.1± 25.6 mg/dL, P = 0.81) and between normal-weight control subjects and remitters (70.4 ± 22.9 vs 77.2 ± 25.8 mg/dL, P = 0.39). Total cholesterol was also significantly higher in nonremitters compared with remitters (167.8 ± 30.5 vs 149.8 ± 32.1 mg/dL, P = 0.012) and with normal-weight control subjects (167.8 ± 30.5 vs 143.2 ± 30.1 mg/dL, P = 0.011) but was similar between nonremitters and overweight/obese control subjects (P = 0.098) and between remitters and normal-weight control subjects (P = 0.51). Non–high-density lipoprotein cholesterol was equally significantly higher in nonremitters compared with remitters (111.3 ± 30.1 vs 95.9 ± 29.1 mg/dL, P = 0.028) and normal-weight control subjects (111.3 ± 30.1 vs 86.2 ± 32.2 mg/dL, P = 0.028) but was similar between nonremitters and overweight/obese control subjects (P = 0.48) and between remitters vs normal-weight control subjects (P = 0.39). CONCLUSIONS: Puberty-related reductions in low-density lipoprotein, total cholesterol, and non–high-density lipoprotein occur in remitters and normal-weight control subjects but not in nonremitters and overweight/obese control subjects.
format Online
Article
Text
id pubmed-6436764
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-64367642019-03-29 Pubertal Lipid Levels Are Significantly Lower in Youth With Type 1 Diabetes Who Experienced Partial Clinical Remission Nwosu, Benjamin Udoka Rupendu, Shwetha Zitek-Morrison, Emily Patel, Deepa Villalobos-Ortiz, Tony R Jasmin, Gabrielle Barton, Bruce A J Endocr Soc Clinical Research Articles IMPORTANCE: The physiologic changes in lipids during puberty in type 1 diabetes (T1D) are unclear because subjects in previous studies were not stratified by partial clinical remission status. AIM: To determine the effect of partial clinical remission on lipid changes during puberty in youth with T1D. SUBJECTS AND METHODS: A retrospective cross-sectional study of 194 subjects consisting of 71 control subjects of age 12.9 ± 1.3 years and 123 subjects with T1D stratified into remitters (n = 44; age, 13.0 ± 0.8 years) and nonremitters (n = 79; age, 11.2 ± 0.6 years). Partial clinical remission was defined as insulin-dose adjusted HbA1c of ≤9. Pubertal status was determined by Tanner staging. RESULTS: Among the pubertal cohort, low-density lipoprotein cholesterol concentration was significantly higher in the nonremitters compared with remitters (91.1 ± 25.6 vs 77.2 ± 25.8 mg/dL, P = 0.018) and with normal-weight control subjects (91.1 ± 25.6 vs 70.4 ± 22.9 mg/dL, P = 0.009) but was similar between overweight/obese control subjects and nonremitters (89.7 ± 28.9 vs 91.1± 25.6 mg/dL, P = 0.81) and between normal-weight control subjects and remitters (70.4 ± 22.9 vs 77.2 ± 25.8 mg/dL, P = 0.39). Total cholesterol was also significantly higher in nonremitters compared with remitters (167.8 ± 30.5 vs 149.8 ± 32.1 mg/dL, P = 0.012) and with normal-weight control subjects (167.8 ± 30.5 vs 143.2 ± 30.1 mg/dL, P = 0.011) but was similar between nonremitters and overweight/obese control subjects (P = 0.098) and between remitters and normal-weight control subjects (P = 0.51). Non–high-density lipoprotein cholesterol was equally significantly higher in nonremitters compared with remitters (111.3 ± 30.1 vs 95.9 ± 29.1 mg/dL, P = 0.028) and normal-weight control subjects (111.3 ± 30.1 vs 86.2 ± 32.2 mg/dL, P = 0.028) but was similar between nonremitters and overweight/obese control subjects (P = 0.48) and between remitters vs normal-weight control subjects (P = 0.39). CONCLUSIONS: Puberty-related reductions in low-density lipoprotein, total cholesterol, and non–high-density lipoprotein occur in remitters and normal-weight control subjects but not in nonremitters and overweight/obese control subjects. Endocrine Society 2019-02-27 /pmc/articles/PMC6436764/ /pubmed/30931423 http://dx.doi.org/10.1210/js.2019-00016 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research Articles
Nwosu, Benjamin Udoka
Rupendu, Shwetha
Zitek-Morrison, Emily
Patel, Deepa
Villalobos-Ortiz, Tony R
Jasmin, Gabrielle
Barton, Bruce A
Pubertal Lipid Levels Are Significantly Lower in Youth With Type 1 Diabetes Who Experienced Partial Clinical Remission
title Pubertal Lipid Levels Are Significantly Lower in Youth With Type 1 Diabetes Who Experienced Partial Clinical Remission
title_full Pubertal Lipid Levels Are Significantly Lower in Youth With Type 1 Diabetes Who Experienced Partial Clinical Remission
title_fullStr Pubertal Lipid Levels Are Significantly Lower in Youth With Type 1 Diabetes Who Experienced Partial Clinical Remission
title_full_unstemmed Pubertal Lipid Levels Are Significantly Lower in Youth With Type 1 Diabetes Who Experienced Partial Clinical Remission
title_short Pubertal Lipid Levels Are Significantly Lower in Youth With Type 1 Diabetes Who Experienced Partial Clinical Remission
title_sort pubertal lipid levels are significantly lower in youth with type 1 diabetes who experienced partial clinical remission
topic Clinical Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436764/
https://www.ncbi.nlm.nih.gov/pubmed/30931423
http://dx.doi.org/10.1210/js.2019-00016
work_keys_str_mv AT nwosubenjaminudoka pubertallipidlevelsaresignificantlylowerinyouthwithtype1diabeteswhoexperiencedpartialclinicalremission
AT rupendushwetha pubertallipidlevelsaresignificantlylowerinyouthwithtype1diabeteswhoexperiencedpartialclinicalremission
AT zitekmorrisonemily pubertallipidlevelsaresignificantlylowerinyouthwithtype1diabeteswhoexperiencedpartialclinicalremission
AT pateldeepa pubertallipidlevelsaresignificantlylowerinyouthwithtype1diabeteswhoexperiencedpartialclinicalremission
AT villalobosortiztonyr pubertallipidlevelsaresignificantlylowerinyouthwithtype1diabeteswhoexperiencedpartialclinicalremission
AT jasmingabrielle pubertallipidlevelsaresignificantlylowerinyouthwithtype1diabeteswhoexperiencedpartialclinicalremission
AT bartonbrucea pubertallipidlevelsaresignificantlylowerinyouthwithtype1diabeteswhoexperiencedpartialclinicalremission